Serum Lipopolysaccharide Is Associated with the Recurrence of Atrial Fibrillation after Radiofrequency Ablation by Increasing Systemic Inflammation and Atrial Fibrosis
Table 3
Univariate and multivariable linear regression analysis for the correlation of between Log-LPS with anthropometric and biochemical variables.
Variables
Univariate
Multivariable
Standardized β
95% CI
Standardized β
95% CI
Age (year)
0.089
-0.002-0.008
0.267
Male, (%)
-0.057
-0.143-0.067
0.472
Persistent AF, (%)
0.132
-0.016-0.191
0.098
Hypertension, (%)
0.125
-0.020-0.183
0.116
Diabetes, (%)
0.121
-0.034-0.266
0.128
CHD, (%)
0.078
-0.062-0.184
0.328
Heart failure, (%)
0.255
0.081-0.323
0.001
0.138
-0.010-0.228
0.071
BMI (kg/m2)
0.007
-0.016-0.017
0.926
Glu (mmol/L)
-0.030
-0.029-0.021
0.743
LDL (mmol/L)
0.087
-0.028-0.099
0.275
TG (mmol/L)
0.078
-0.027-0.080
0.328
Cr (μmol/L)
0.016
-0.002-0.003
0.837
LAD (mm)
0.227
0.004-0.021
0.004
0.144
0.001-0.016
0.057
Hs-CRP (mg/L)
0.271
0.175-0.619
0.001
0.215
0.105-0.525
0.003
IL-6 (pg/mL)
0.289
0.002-0.007
< 0.001
0.182
0.001-0.005
0.016
CITP (ng/mL)
0.179
0.042-0.589
0.024
0.123
-0.036-0.469
0.092
TGF-β1 (ng/mL)
0.197
0.001-0.008
0.013
0.144
0.001-0.006
0.050
CHD: coronary heart disease; BMI: body mass index; LAD: left atrial diameter; IL-6: interleukin-6; CITP: collagen type-1 C-terminal telopeptide; TGF-β1: transforming growth factor beta1; LPS: lipopolysaccharide.
